Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy

Current Eye Research

Volumn 33, Issue 5-6, 2008, Pages 421-427

  Hondur, Ahmet ^a,b   Konuk, Onur ^a   Dincel, Aylin Sepici ^a   Bilgihan, Ayse ^a   Unal, Mehmet ^a   Hasanreisoglu, Berati ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Department of Biochemistry ^*  (Turkey)

Author keywords

Antioxidant activity; Antioxidant treatment; Graves' ophthalmopathy; Oxidative stress

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID HYDROPEROXIDE; SUPEROXIDE DISMUTASE;

ADIPOSE TISSUE; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DECOMPRESSION SURGERY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENDOCRINE OPHTHALMOPATHY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; THYROID DISEASE;

ADIPOSE TISSUE; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DECOMPRESSION, SURGICAL; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GRAVES OPHTHALMOPATHY; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; ORBIT; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 47349098852     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680802123532     Document Type: Article

References (38)

1. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: Reality and perspectives. Endocr Rev. 2000;21:168-199.
2. Burch HB, Wartofsky L. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev. 1993;14:747-793.
3. Heufelder AE, Wenzel BE, Bahn RS. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts. J Clin Endocrinol Metab. 1992;74:737-742.
4. Korducki JM, Loftus SJ, Bahn RS. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:2037-2042.
5. Chang CC, Chang TC, Kao SC, Kuo YF, Chien LF. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema. Acta Endocrinol (Copenh). 1993;129:322-327.
6. Burch HB, Lahiri S, Bahn RS, Barnes S. Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy. Exp Eye Res. 1997;65:311-316.
7. Hiromatsu Y, Yang D, Miyake I, Koga M, Kameo J, Sato M, Inoue Y, Nonaka K. Nicotinamide decreases cytokine-induced activation of orbital fibroblasts from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 1998;83:121-124.
8. Balazs C, Kiss H, Farid NR. Inhibitory effect of pentoxifylline on HLADR expression and glycosaminoglycan synthesis by retrobulbar fibroblasts. Horm Metab Res. 1998;30:496-499.
9. Smith TJ, Bahn RS, Gorman CA, Cheavens M. Stimulation of glycosaminoglycan accumulation by interferon ? in cultured human retroocular fibroblasts. J Clin Endocrinol Metab. 1999;72:1169-1171.
10. Lu R, Wang P, Wartofsky L, Sutton BD, Zweier JL, Bahn RS, Garrity J, Burman KD. Oxygen free radicals in interleukin-1β-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients. Thyroid. 1999;9:297-303.
11. Bhat VB, Madyastha KM. Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. Biochem Biophys Res Commun. 2001;288:1212-1217.
12. Bartalena L, Tanda ML, Piantanida E, Lai A. Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications. Biofactors. 2003;19:155-163.
13. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab. 2001;86:3562-3567.
14. Bartalena L, Marcocci C, Pinchera A. Treating severe Graves' ophthalmopathy. Bailliere's Clin Endocrinol Metab. 1997;11:521-536.
15. Bartalena L, Marcocci C, Pinchera A. Management of thyroid eye disease. Eur J Nucl Med. 2002;29:S458-S465.
16. Bouzas EA, Karadimas P, Mastorakos G, Koutras DA. Antioxidant agents in the treatment of Graves' ophthalmopathy. Am J Ophthalmol. 2000;129:618-622.
17. Balazs C, Kiss E, Vamos A, Molnar I, Farid NR. Beneficial effect of pentoxifylline on thyroid associated ophthalmopathy (TAO): A pilot study. J Clin Endocrinol Metab. 1997;82:1999-2002.
18. Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE, Halkias A. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: The first European Group on Graves' orbitopathy experience. Eur J Endocrinol. 2003;148:491-495.
19. Werner SC. Classification of the eye changes of Graves' disease. J Clin Endocrinol Metab. 1969;29:982-984.
20. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol. 1997;47:9-14.
21. Nunery WR, Martin RT, Heinz GW, et al. The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease. Ophthal Plast Reconstr Surg. 1993;9:7714.
22. Mihaljevic B, Katusin-Razem B, Razem D. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med. 1996;21:53-63.
23. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502-522.
24. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106:207-212.
25. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
26. Carlberg I, Mannervik B. Purification and characterization of glutathione reductase from calf liver. An improved procedure for affinity chromatography on 2′,5′-ADP-Sepharose 4B. Anal Biochem. 1981;116:531-536.
27. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-169.
28. Mishra OP, Delivoria-Papadopoulos M, Wagerle LC. Anti-oxidant enzymes in the brain of newborn piglets during ischemia followed by reperfusion. Neuroscience. 1990;35:211-215.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
30. Hiromatsu Y, Sato M, Yamada K, Nonaka K. Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells. Clin Endocrinol (Oxf). 1992;36:91-95.
31. Hiromatsu Y, Sato M, Tanaka K, Ishisaka N, Kamachi J, Nonaka K. Inhibitory effects of nicotinamide on intercellular adhesion molecule1 expression on cultured human thyroid cells. Immunology. 1993;80:330-332.
32. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449-1456.
33. Hegedius L, Brix TH, Vestergaard P. Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest. 2004;27:265-271.
34. Metcalfe RA, Weetman AP. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: Possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf). 1994;40:67-72.
35. Cheng AC, Pang CP, Leung AT, Chua JK, Fan DS, Lam DS. The association between cigarette smoking and ocular diseases. Hong Kong Med J. 2000;6:195-202.
36. Palmer T. Understanding Enzymes. New York: Ellis Horwood Limited; 1991.
37. Kumar S, Bahn RS. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 2003;88:4246-4250.
38. Konuk O, Hondur A, Akyurek N, Unal M. Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy. Ocular Immunol Inflamm. 2007;15:1-7.